Literature DB >> 6950936

Histone hypoacetylation following release of HTC cells from butyrate.

J Covault, L Sealy, R Schnell, A Shires, R Chalkley.   

Abstract

Exposure of HTC cells to 6 mM sodium butyrate for 20 h results in significantly reduced amounts of nuclear histone acetyltransferase. While the direct butyrate inhibition of histone deacetylases is rapidly reversed upon removal of cells from butyrate, histone acetyltransferase activity increases only gradually following release of cells from butyrate, requiring several hours to regain control cell levels. As a result, HTC cells released from a 20-h exposure to butyrate display normal kinetics of histone acetate turnover but markedly reduced rates of histone acetylation, the imbalance in these two processes produces histone hypoacetylation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6950936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Relationship of histone acetylation to DNA topology and transcription.

Authors:  W A Krajewski; A N Luchnik
Journal:  Mol Gen Genet       Date:  1991-12

2.  Hyperacetylated histones facilitate chromatin assembly in vitro.

Authors:  M Cotten; R Chalkley
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

3.  Effects of myogenin on expression of late muscle genes through MyoD-dependent chromatin remodeling ability of myogenin.

Authors:  Chao Du; Ya-Qiong Jin; Jun-Juan Qi; Zhen-Xing Ji; Shu-Yan Li; Guo-Shun An; Hong-Ti Jia; Ju-Hua Ni
Journal:  Mol Cells       Date:  2012-07-18       Impact factor: 5.034

Review 4.  DNA-protein interactions and spatial organization of DNA.

Authors:  W A Krajewski; S V Razin
Journal:  Mol Biol Rep       Date:  1993-10       Impact factor: 2.316

5.  Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA production.

Authors:  M Abe; D W Kufe
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.